New & Novel Webinar Series

The field of immunotherapy for solid cancers is rapidly expanding beyond immune checkpoint inhibitors, bringing new challenges and toxicities for healthcare professionals to navigate.

To address these issues, the IOCN is hosting a 'New and Novel' webinar series. This series will consist of four webinars focused on cutting-edge immunotherapeutics and their associated side effects, including CRS, HLH, and ICANS.

Each webinar will be led by experts in the field, with ample opportunity for attendees to ask questions.Join us for this informative series to deepen your understanding of novel immunotherapeutics and their side effects.

If you have any questions or queries please email enquiries@ioclinicanetwork.co.uk.

This webinar series is kindly sponsored by Amgen, who have had no involvement in the production of the agenda for this webinar.